IMVT vs. XMMO
Compare and contrast key facts about Immunovant, Inc. (IMVT) and Invesco S&P MidCap Momentum ETF (XMMO).
XMMO is a passively managed fund by Invesco that tracks the performance of the S&P MidCap 400 Index. It was launched on Mar 3, 2005.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IMVT or XMMO.
Key characteristics
| IMVT | XMMO | |
|---|---|---|
| YTD Return | -31.40% | 31.61% |
| 1Y Return | 34.54% | 45.47% |
| 3Y Return (Ann) | 48.68% | 12.00% |
| 5Y Return (Ann) | 23.78% | 16.00% |
| Sharpe Ratio | 0.29 | 2.27 |
| Daily Std Dev | 109.18% | 20.22% |
| Max Drawdown | -93.59% | -55.37% |
| Current Drawdown | -45.17% | -2.22% |
Correlation
The correlation between IMVT and XMMO is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
IMVT vs. XMMO - Performance Comparison
In the year-to-date period, IMVT achieves a -31.40% return, which is significantly lower than XMMO's 31.61% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
IMVT vs. XMMO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Immunovant, Inc. (IMVT) and Invesco S&P MidCap Momentum ETF (XMMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IMVT vs. XMMO - Dividend Comparison
IMVT has not paid dividends to shareholders, while XMMO's dividend yield for the trailing twelve months is around 0.24%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IMVT Immunovant, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XMMO Invesco S&P MidCap Momentum ETF | 0.24% | 0.80% | 1.43% | 0.41% | 0.61% | 0.60% | 0.19% | 0.21% | 0.22% | 0.64% | 1.24% | 1.30% |
Drawdowns
IMVT vs. XMMO - Drawdown Comparison
The maximum IMVT drawdown since its inception was -93.59%, which is greater than XMMO's maximum drawdown of -55.37%. Use the drawdown chart below to compare losses from any high point for IMVT and XMMO. For additional features, visit the drawdowns tool.
Volatility
IMVT vs. XMMO - Volatility Comparison
Immunovant, Inc. (IMVT) has a higher volatility of 15.57% compared to Invesco S&P MidCap Momentum ETF (XMMO) at 6.44%. This indicates that IMVT's price experiences larger fluctuations and is considered to be riskier than XMMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.